343 related articles for article (PubMed ID: 34769212)
21. Advances in strategies to improve drug delivery to brain tumors.
Newton HB
Expert Rev Neurother; 2006 Oct; 6(10):1495-509. PubMed ID: 17078789
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous.
Drapeau A; Fortin D
Curr Cancer Drug Targets; 2015; 15(9):752-68. PubMed ID: 26077730
[TBL] [Abstract][Full Text] [Related]
23. Brain Cancer: Implication to Disease, Therapeutic Strategies and Tumor Targeted Drug Delivery Approaches.
Shah V; Kochar P
Recent Pat Anticancer Drug Discov; 2018; 13(1):70-85. PubMed ID: 29189177
[TBL] [Abstract][Full Text] [Related]
24. Targeted brain delivery nanoparticles for malignant gliomas.
Pinto MP; Arce M; Yameen B; Vilos C
Nanomedicine (Lond); 2017 Jan; 12(1):59-72. PubMed ID: 27876436
[TBL] [Abstract][Full Text] [Related]
25. Recent advances in nano delivery systems for blood-brain barrier (BBB) penetration and targeting of brain tumors.
Reddy S; Tatiparti K; Sau S; Iyer AK
Drug Discov Today; 2021 Aug; 26(8):1944-1952. PubMed ID: 33865978
[TBL] [Abstract][Full Text] [Related]
26. Overcoming the blood-brain barrier for chemotherapy: limitations, challenges and rising problems.
Wang Z; Sun H; Yakisich JS
Anticancer Agents Med Chem; 2014; 14(8):1085-93. PubMed ID: 23092271
[TBL] [Abstract][Full Text] [Related]
27. Insights into Targeted and Stimulus-Responsive Nanocarriers for Brain Cancer Treatment.
Abousalman-Rezvani Z; Refaat A; Dehghankelishadi P; Roghani-Mamaqani H; Esser L; Voelcker NH
Adv Healthc Mater; 2024 May; 13(12):e2302902. PubMed ID: 38199238
[TBL] [Abstract][Full Text] [Related]
28. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
Wang D; Wang C; Wang L; Chen Y
Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
[TBL] [Abstract][Full Text] [Related]
29. Carbon nanostructures: The drug and the delivery system for brain disorders.
Henna TK; Raphey VR; Sankar R; Ameena Shirin VK; Gangadharappa HV; Pramod K
Int J Pharm; 2020 Sep; 587():119701. PubMed ID: 32736018
[TBL] [Abstract][Full Text] [Related]
30. Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain.
Kreuter J
J Nanosci Nanotechnol; 2004 May; 4(5):484-8. PubMed ID: 15503433
[TBL] [Abstract][Full Text] [Related]
31. Getting to the brain.
Baratta MG
Nat Nanotechnol; 2018 Jul; 13(7):536. PubMed ID: 29921944
[No Abstract] [Full Text] [Related]
32. Overcoming Barriers in Glioblastoma-Advances in Drug Delivery Strategies.
Ter Linden E; Abels ER; van Solinge TS; Neefjes J; Broekman MLD
Cells; 2024 Jun; 13(12):. PubMed ID: 38920629
[TBL] [Abstract][Full Text] [Related]
33. Micro-Nanocarriers Based Drug Delivery Technology for Blood-Brain Barrier Crossing and Brain Tumor Targeting Therapy.
Wang L; Shi Y; Jiang J; Li C; Zhang H; Zhang X; Jiang T; Wang L; Wang Y; Feng L
Small; 2022 Nov; 18(45):e2203678. PubMed ID: 36103614
[TBL] [Abstract][Full Text] [Related]
34. Drug delivery to brain tumors.
Blakeley J
Curr Neurol Neurosci Rep; 2008 May; 8(3):235-41. PubMed ID: 18541119
[TBL] [Abstract][Full Text] [Related]
35. iRGD and TGN co-modified PAMAM for multi-targeted delivery of ATO to gliomas.
Shi X; Ma R; Lu Y; Cheng Y; Fan X; Zou J; Zheng H; Li F; Piao JG
Biochem Biophys Res Commun; 2020 Jun; 527(1):117-123. PubMed ID: 32446354
[TBL] [Abstract][Full Text] [Related]
36. Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.
Papademetriou IT; Porter T
Ther Deliv; 2015; 6(8):989-1016. PubMed ID: 26488496
[TBL] [Abstract][Full Text] [Related]
37. Drug delivery and targeting to brain tumors: considerations for crossing the blood-brain barrier.
Omidi Y; Kianinejad N; Kwon Y; Omidian H
Expert Rev Clin Pharmacol; 2021 Mar; 14(3):357-381. PubMed ID: 33554678
[No Abstract] [Full Text] [Related]
38. Antibody Conjugated Nano-Enabled Drug Delivery Systems Against Brain Tumors.
Topçu BT; Bozdağ Pehlivan S; Akdağ Y; Mut M; Öner L
J Pharm Sci; 2024 Jun; 113(6):1455-1469. PubMed ID: 38555997
[TBL] [Abstract][Full Text] [Related]
39. Nanocarrier-based drug combination therapy for glioblastoma.
Zhao M; van Straten D; Broekman MLD; Préat V; Schiffelers RM
Theranostics; 2020; 10(3):1355-1372. PubMed ID: 31938069
[TBL] [Abstract][Full Text] [Related]
40. Covalent nano delivery systems for selective imaging and treatment of brain tumors.
Ljubimova JY; Sun T; Mashouf L; Ljubimov AV; Israel LL; Ljubimov VA; Falahatian V; Holler E
Adv Drug Deliv Rev; 2017 Apr; 113():177-200. PubMed ID: 28606739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
